Basic information
Biomarker: melatonin
Histology type: endometrial carcinoma
Cohort characteristics
Country: Austria
Region: Vienna
Study type: Comparative Study
Followed up time :
| Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
|---|---|---|---|---|---|---|---|---|
| 138 | EC | 68 | abnormal bleeding | 70 |
Sample information
Conclusion: We conclude that decreasing melatonin plasma levels may be an indicator of endometrial cancer and that this may therefore be used as a reliable screening parameter.
Sample type : plasma
Sample method: EDTA-plasma probes
Expression pattern : deficiency
Disease information
Related information
UniProt Link:
Molecular function from UniProt:
